US Stock MarketDetailed Quotes

SPRO Spero Therapeutics

Watchlist

1.145
-0.045-3.78%

Trading Nov 22 12:14 ET

62.42MMarket Cap14.31P/E (TTM)

Spero Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-19.81%12.76M

-0.97%-18.74M

146.20%5.94M

-326.79%-33M

-139.33%-17.49M

1,763.01%15.92M

19.40%-18.56M

54.46%-12.85M

87.99%-7.73M

262.65%44.48M

Net income from continuing operations

-435.01%-17.15M

-49.92%-17.86M

4.50%-12.67M

149.13%22.81M

91.22%51.19M

72.55%-3.21M

58.46%-11.91M

59.59%-13.27M

48.29%-46.42M

191.56%26.77M

Operating gains losses

----

1,500.00%2.67M

33.17%-139K

Depreciation and amortization

--0

-98.15%2K

--0

-57.77%367K

-70.54%38K

-57.98%108K

-63.27%108K

-40.21%113K

34.52%869K

-32.46%129K

Other non cash items

7.79%263K

7.50%258K

7.63%254K

-70.48%969K

7.33%249K

7.02%244K

110.53%240K

-91.29%236K

36.17%3.28M

-87.11%232K

Change In working capital

137.95%27.49M

63.24%-3.26M

875.40%16.33M

-418.63%-70.38M

-573.37%-70.97M

54.78%11.55M

-765.79%-8.86M

-23.88%-2.11M

71.72%22.09M

621.64%14.99M

-Change in receivables

326.19%2.04M

226.91%283K

-344.56%-3.47M

-129.80%-461K

1,202.29%1.44M

-244.39%-901K

-156.74%-223K

-218.15%-781K

-59.63%1.55M

-147.17%-131K

-Change in prepaid assets

-63.93%1.14M

109.39%472K

410.98%510K

-115.24%-799K

165.04%1.23M

-9.29%3.16M

-239.09%-5.03M

-629.03%-164K

286.68%5.24M

66.03%-1.89M

-Change in payables and accrued expense

1,053.77%8.71M

268.15%4.26M

452.41%511K

78.37%-1.27M

160.35%656K

66.67%755K

29.92%-2.53M

91.00%-145K

-385.07%-5.86M

-133.61%-1.09M

-Change in other current assets

--24.04M

---1.94M

--23.33M

-3,191,333.33%-95.74M

-9,574,200.00%-95.74M

--0

99.06%-3K

99.69%-1K

-Change in other current liabilities

-12.71%-328K

-12.32%-319K

-26.09%-348K

-52.47%-1.11M

1.13%-262K

-164.55%-291K

-170.48%-284K

-10.40%-276K

-34.69%-730K

-388.04%-265K

-Change in other working capital

-191.87%-8.11M

-665.27%-6.02M

-468.24%-4.21M

32.51%29.01M

18.18%21.71M

125.32%8.83M

-434.69%-786K

-200.81%-740K

105.69%21.89M

7,302.75%18.37M

Cash from discontinued investing activities

Operating cash flow

-19.81%12.76M

-0.97%-18.74M

146.20%5.94M

-326.79%-33M

-139.33%-17.49M

1,763.01%15.92M

19.40%-18.56M

54.46%-12.85M

87.99%-7.73M

262.65%44.48M

Investing cash flow

Cash flow from continuing investing activities

340.65%33.81M

Net investment purchase and sale

----

--0

----

342.91%33.81M

--0

Cash from discontinued investing activities

Investing cash flow

----

--0

----

340.65%33.81M

--0

Financing cash flow

Cash flow from continuing financing activities

100.75%221K

-99.99%1K

-135.16%-29.55M

-71.84%14.18M

Net common stock issuance

----

-99.10%221K

-99.99%1K

----

-30.69%24.51M

473.08%14.18M

Proceeds from stock option exercised by employees

----

--0

----

-71.03%420K

-99.57%1K

Net other financing activities

----

-215.36%-54.49M

--0

Cash from discontinued financing activities

Financing cash flow

----

100.75%221K

-99.99%1K

----

-135.16%-29.55M

-71.84%14.18M

Net cash flow

Beginning cash position

-18.23%63.53M

-14.53%82.27M

-30.04%76.33M

-3.09%109.11M

85.99%93.83M

71.12%77.69M

33.48%96.25M

-3.09%109.11M

32.13%112.58M

-55.30%50.45M

Current changes in cash

-20.90%12.76M

-0.97%-18.74M

146.20%5.94M

-842.59%-32.77M

-129.82%-17.49M

219.82%16.14M

30.50%-18.56M

68.24%-12.85M

-112.70%-3.48M

21,431.27%58.66M

End cash Position

-18.69%76.29M

-18.23%63.53M

-14.53%82.27M

-30.04%76.33M

85.99%93.83M

71.12%77.69M

33.48%96.25M

-3.09%109.11M

Free cash flow

-19.81%12.76M

-0.97%-18.74M

146.20%5.94M

-326.79%-33M

-139.33%-17.49M

1,763.01%15.92M

19.40%-18.56M

54.46%-12.85M

87.99%-7.73M

262.65%44.48M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-19.81%12.76M	-0.97%-18.74M	146.20%5.94M	-326.79%-33M	-139.33%-17.49M	1,763.01%15.92M	19.40%-18.56M	54.46%-12.85M	87.99%-7.73M	262.65%44.48M
Net income from continuing operations	-435.01%-17.15M	-49.92%-17.86M	4.50%-12.67M	149.13%22.81M	91.22%51.19M	72.55%-3.21M	58.46%-11.91M	59.59%-13.27M	48.29%-46.42M	191.56%26.77M
Operating gains losses	----	----	----	----	----	----	----	----	1,500.00%2.67M	33.17%-139K
Depreciation and amortization	--0	-98.15%2K	--0	-57.77%367K	-70.54%38K	-57.98%108K	-63.27%108K	-40.21%113K	34.52%869K	-32.46%129K
Other non cash items	7.79%263K	7.50%258K	7.63%254K	-70.48%969K	7.33%249K	7.02%244K	110.53%240K	-91.29%236K	36.17%3.28M	-87.11%232K
Change In working capital	137.95%27.49M	63.24%-3.26M	875.40%16.33M	-418.63%-70.38M	-573.37%-70.97M	54.78%11.55M	-765.79%-8.86M	-23.88%-2.11M	71.72%22.09M	621.64%14.99M
-Change in receivables	326.19%2.04M	226.91%283K	-344.56%-3.47M	-129.80%-461K	1,202.29%1.44M	-244.39%-901K	-156.74%-223K	-218.15%-781K	-59.63%1.55M	-147.17%-131K
-Change in prepaid assets	-63.93%1.14M	109.39%472K	410.98%510K	-115.24%-799K	165.04%1.23M	-9.29%3.16M	-239.09%-5.03M	-629.03%-164K	286.68%5.24M	66.03%-1.89M
-Change in payables and accrued expense	1,053.77%8.71M	268.15%4.26M	452.41%511K	78.37%-1.27M	160.35%656K	66.67%755K	29.92%-2.53M	91.00%-145K	-385.07%-5.86M	-133.61%-1.09M
-Change in other current assets	--24.04M	---1.94M	--23.33M	-3,191,333.33%-95.74M	-9,574,200.00%-95.74M	--0	--0	--0	99.06%-3K	99.69%-1K
-Change in other current liabilities	-12.71%-328K	-12.32%-319K	-26.09%-348K	-52.47%-1.11M	1.13%-262K	-164.55%-291K	-170.48%-284K	-10.40%-276K	-34.69%-730K	-388.04%-265K
-Change in other working capital	-191.87%-8.11M	-665.27%-6.02M	-468.24%-4.21M	32.51%29.01M	18.18%21.71M	125.32%8.83M	-434.69%-786K	-200.81%-740K	105.69%21.89M	7,302.75%18.37M
Cash from discontinued investing activities
Operating cash flow	-19.81%12.76M	-0.97%-18.74M	146.20%5.94M	-326.79%-33M	-139.33%-17.49M	1,763.01%15.92M	19.40%-18.56M	54.46%-12.85M	87.99%-7.73M	262.65%44.48M
Investing cash flow
Cash flow from continuing investing activities				0					340.65%33.81M	0
Net investment purchase and sale	----	----	----	--0	----	----	----	----	342.91%33.81M	--0
Cash from discontinued investing activities
Investing cash flow	----	----	----	--0	----	----	----	----	340.65%33.81M	--0
Financing cash flow
Cash flow from continuing financing activities				100.75%221K	-99.99%1K				-135.16%-29.55M	-71.84%14.18M
Net common stock issuance	----	----	----	-99.10%221K	-99.99%1K	----	----	----	-30.69%24.51M	473.08%14.18M
Proceeds from stock option exercised by employees	----	----	----	--0	----	----	----	----	-71.03%420K	-99.57%1K
Net other financing activities	----	----	----	----	----	----	----	----	-215.36%-54.49M	--0
Cash from discontinued financing activities
Financing cash flow	----	----	----	100.75%221K	-99.99%1K	----	----	----	-135.16%-29.55M	-71.84%14.18M
Net cash flow
Beginning cash position	-18.23%63.53M	-14.53%82.27M	-30.04%76.33M	-3.09%109.11M	85.99%93.83M	71.12%77.69M	33.48%96.25M	-3.09%109.11M	32.13%112.58M	-55.30%50.45M
Current changes in cash	-20.90%12.76M	-0.97%-18.74M	146.20%5.94M	-842.59%-32.77M	-129.82%-17.49M	219.82%16.14M	30.50%-18.56M	68.24%-12.85M	-112.70%-3.48M	21,431.27%58.66M
End cash Position	-18.69%76.29M	-18.23%63.53M	-14.53%82.27M	-30.04%76.33M	-30.04%76.33M	85.99%93.83M	71.12%77.69M	33.48%96.25M	-3.09%109.11M	-3.09%109.11M
Free cash flow	-19.81%12.76M	-0.97%-18.74M	146.20%5.94M	-326.79%-33M	-139.33%-17.49M	1,763.01%15.92M	19.40%-18.56M	54.46%-12.85M	87.99%-7.73M	262.65%44.48M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data